Article
Envision Pharma Group
Building Winning Oncology Teams That Last
Clips
Summary
In this episode of the Oncology Voice Network, Dr. Kirk Shepard sits down with Spencer Weneck and Christian Camp to break down what truly makes an oncology organization resilient, competitive, and future-ready.
How do leading pharma and biotech teams keep up with oncology’s relentless pace? In this episode of the Oncology Voice Network, Dr. Kirk Shepard sits down with Spencer Weneck and Christian Camp to break down what truly makes an oncology organization resilient, competitive, and future-ready. Hear firsthand insights into today’s most urgent challenges: navigating the shift from an employer to a candidate-driven market, adapting to patent cliffs and M&A waves, and outsmarting the industry’s unparalleled war for talent. Discover why talent development, cultural fit, and cross-functional leadership are make-or-break factors—and why so many companies lose their way by ignoring them. Get inspired by real-life examples, honest lessons from failure, and a deep dive into how shared learning environments like OVN are resetting industry standards. Listen now and future-proof your oncology team.
Related Topics
You May Also Like
Envision Pharma Group
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care
Article
iNIZIO